Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
My Best Dividend Aristocrats For March 2025
03:59pm, Thursday, 27'th Feb 2025
The ProShares S&P 500 Dividend Aristocrat ETF kicks off 2025 on a bright note with a gain of 2.81% in January. I present 3 strategies that can theoretically beat the dividend aristocrat index in the l
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Thursday, 27'th Feb 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
2025 Dividend Kings - Off To A Strong Start
07:07pm, Wednesday, 26'th Feb 2025
The Dividend Kings are outperforming the S&P 500 in 2025, up 4% YTD versus 1.39% for SPY. Ten Dividend Kings have already achieved double-digit returns, led by National Fuel Gas (+22.08%) and Abbott L
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 25'th Feb 2025
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott Declares 405th Consecutive Quarterly Dividend
10:48am, Friday, 21'st Feb 2025
ABBOTT PARK, Ill., Feb. 21, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know
07:01pm, Thursday, 20'th Feb 2025
The latest trading day saw Abbott (ABT) settling at $133.17, representing a +0.79% change from its previous close.
Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
10:45am, Wednesday, 19'th Feb 2025
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
AHCO or ABT: Which Is the Better Value Stock Right Now?
12:46pm, Thursday, 13'th Feb 2025
Investors looking for stocks in the Medical - Products sector might want to consider either AdaptHealth Corp. (AHCO) or Abbott (ABT). But which of these two stocks is more attractive to value investor
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
10:05am, Thursday, 13'th Feb 2025
DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching U
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
06:35am, Thursday, 13'th Feb 2025
Most companies don't survive for decades, much less pay regular dividends for that long. However, some rare corporations can pull it off.
ABT Stock Jumps 12% Since Q4 Earnings: Time to Invest in Abbott?
12:55pm, Wednesday, 12'th Feb 2025
Abbott projects organic sales growth between 7.5% and 8.5% for 2025.
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:01am, Tuesday, 11'th Feb 2025
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
04:20am, Monday, 10'th Feb 2025
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative biotech that may launch game-changing products down the road.
Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility
04:56pm, Friday, 07'th Feb 2025
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week.
Here are the best performing dividend aristocrats stocks in 2025
11:03pm, Wednesday, 05'th Feb 2025
Dividend aristocrat stocks have largely done well in the past few years. The closely-followed ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has jumped by over 133% from its lowest level in 2020.
